Debugging Nano-Bio Interfaces: Systematic Strategies to Accelerate Clinical Translation of Nanotechnologies.

Despite considerable efforts in the field of nanomedicine that have been made by researchers, funding agencies, entrepreneurs, and the media, fewer nanoparticle (NP) technologies than expected have made it to clinical trials. The wide gap between the efforts and effective clinical translation is, at least in part, due to multiple overlooked factors in both in vitro and in vivo environments, a poor understanding of the nano-bio interface, and misinterpretation of the data collected in vitro, all of which reduce the accuracy of predictions regarding the NPs' fate and safety in humans. To minimize this bench-to-clinic gap, which may accelerate successful clinical translation of NPs, this opinion paper aims to introduce strategies for systematic debugging of nano-bio interfaces in the current literature.

[1]  J. Swinnen,et al.  LNCaP prostatic adenocarcinoma cells derived from low and high passage numbers display divergent responses not only to androgens but also to retinoids , 1997, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  Peter Wick,et al.  Nanotoxicology: an interdisciplinary challenge. , 2011, Angewandte Chemie.

[3]  Robert Langer,et al.  Multiscale technologies for treatment of ischemic cardiomyopathy. , 2017, Nature nanotechnology.

[4]  James Chen Yong Kah,et al.  Exploiting the protein corona around gold nanorods for loading and triggered release. , 2012, ACS nano.

[5]  Albert Duschl,et al.  Time evolution of the nanoparticle protein corona. , 2010, ACS nano.

[6]  Giulio Caracciolo,et al.  Size and charge of nanoparticles following incubation with human plasma of healthy and pancreatic cancer patients. , 2014, Colloids and surfaces. B, Biointerfaces.

[7]  A. Doucet-Panaye,et al.  Investigation of the influence of protein corona composition on gold nanoparticle bioactivity using machine learning approaches , 2016, SAR and QSAR in environmental research.

[8]  Logan S. Ahlstrom,et al.  Exploring Protein-Nanoparticle Interactions with Coarse-Grained Protein Folding Models. , 2017, Small.

[9]  K. Landfester,et al.  Visualization of the protein corona: towards a biomolecular understanding of nanoparticle-cell-interactions. , 2017, Nanoscale.

[10]  A. J. Tavares,et al.  Analysis of nanoparticle delivery to tumours , 2016 .

[11]  Marco P Monopoli,et al.  Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.

[12]  Philip M. Kelly,et al.  Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.

[13]  Stefan Tenzer,et al.  Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. , 2013, Nature nanotechnology.

[14]  Timothy J Shaw,et al.  Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects. , 2009, Small.

[15]  Iseult Lynch,et al.  The evolution of the protein corona around nanoparticles: a test study. , 2011, ACS nano.

[16]  W. Malorni,et al.  Sex differences at cellular level: "cells have a sex". , 2012, Handbook of experimental pharmacology.

[17]  Jong-Min Lim,et al.  Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics , 2017, Nature Communications.

[18]  M. Menziani,et al.  Competitive Binding of Proteins to Gold Nanoparticles Disclosed by Molecular Dynamics Simulations , 2015 .

[19]  Maciej Stępnik,et al.  Inter-laboratory comparison of nanoparticle size measurements using dynamic light scattering and differential centrifugal sedimentation , 2018 .

[20]  G. Woloschak,et al.  Effect of passage number on cellular response to DNA-damaging agents: cell survival and gene expression. , 1997, Cancer letters.

[21]  R. Zare,et al.  Chemical recognition in cell-imprinted polymers. , 2012, ACS nano.

[22]  L. Sargent,et al.  Comparison of Established Cell Lines at Different Passages by Karyotype and Comparative Genomic Hybridization , 2004, Bioscience reports.

[23]  Ke Xu,et al.  Development of a Virtual Cell Model to Predict Cell Response to Substrate Topography. , 2017, ACS nano.

[24]  Morteza Mahmoudi,et al.  Nanoparticle Surface Functionality Dictates Cellular and Systemic Toxicity , 2017 .

[25]  Ingmar Schoen,et al.  Probing fibronectin conformation on a protein corona layer around nanoparticles. , 2018, Nanoscale.

[26]  Younan Xia,et al.  The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles. , 2011, Nature nanotechnology.

[27]  K. Landfester,et al.  Protein corona change the drug release profile of nanocarriers: the "overlooked" factor at the nanobio interface. , 2014, Colloids and surfaces. B, Biointerfaces.

[28]  Nando de Freitas,et al.  An Introduction to MCMC for Machine Learning , 2004, Machine Learning.

[29]  Morteza Mahmoudi,et al.  Personalized protein coronas: a "key" factor at the nanobiointerface. , 2014, Biomaterials science.

[30]  M. Kirschner,et al.  Cell Growth and Size Homeostasis in Proliferating Animal Cells , 2009, Science.

[31]  Alok Dhawan,et al.  Stable colloidal dispersions of C60 fullerenes in water: evidence for genotoxicity. , 2006, Environmental science & technology.

[32]  S. Karim,et al.  Matrix stiffness induces epithelial–mesenchymal transition and promotes chemoresistance in pancreatic cancer cells , 2017, Oncogenesis.

[33]  Valerie M. Weaver,et al.  A tense situation: forcing tumour progression , 2009, Nature Reviews Cancer.

[34]  Morteza Mahmoudi,et al.  Exploring Cellular Interactions of Liposomes Using Protein Corona Fingerprints and Physicochemical Properties. , 2016, ACS nano.

[35]  James Chen Yong Kah,et al.  Optimizing the properties of the protein corona surrounding nanoparticles for tuning payload release. , 2013, ACS nano.

[36]  Seung-Min Park,et al.  Towards clinically translatable in vivo nanodiagnostics. , 2017, Nature reviews. Materials.

[37]  Arthur G Erdman,et al.  The big picture on nanomedicine: the state of investigational and approved nanomedicine products. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[38]  G. Berx,et al.  Regulatory networks defining EMT during cancer initiation and progression , 2013, Nature Reviews Cancer.

[39]  Jim E Riviere,et al.  An index for characterization of nanomaterials in biological systems. , 2010, Nature nanotechnology.

[40]  Morteza Mahmoudi,et al.  Personalized protein corona on nanoparticles and its clinical implications. , 2017, Biomaterials science.

[41]  Kenneth A Dawson.  Leave the policing to others. , 2013, Nature nanotechnology.

[42]  J. A. van Kan,et al.  Stamps for nanoimprint lithography fabricated by proton beam writing and nickel electroplating , 2006 .

[43]  Katharina Landfester,et al.  The Transferability from Animal Models to Humans: Challenges Regarding Aggregation and Protein Corona Formation of Nanoparticles. , 2018, Biomacromolecules.

[44]  Itay Lazar,et al.  The interface of nanoparticles with proliferating mammalian cells. , 2017, Nature nanotechnology.

[45]  V. Muller.  Exploring the biological contributions to human health: does sex matter? , 2001, Journal of women's health & gender-based medicine.

[46]  A. Stammati,et al.  The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics , 2005, Cell Biology and Toxicology.

[47]  M. Vlasova,et al.  Personalized Approach in Nanomedicine: Understanding Adverse Effects and Their Risk Assessment , 2017 .

[48]  M. Mahmoudi,et al.  Protein-nanoparticle interactions: opportunities and challenges. , 2011, Chemical reviews.

[49]  Christoffer Åberg,et al.  Mapping protein binding sites on the biomolecular corona of nanoparticles. , 2015, Nature nanotechnology.

[50]  Wolfgang J Parak,et al.  A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. , 2009, Nature nanotechnology.

[51]  Todd,et al.  Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning , 2002, Nature Medicine.

[52]  Kenneth A. Dawson,et al.  Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. , 2011, Nature nanotechnology.

[53]  Morteza Mahmoudi,et al.  A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles. , 2010, Colloids and surfaces. B, Biointerfaces.

[54]  Raehyun Kim,et al.  The importance of selecting a proper biological milieu for protein corona analysis in vitro: Human plasma versus human serum. , 2016, The international journal of biochemistry & cell biology.

[55]  Heidi Ledford.  Bankruptcy filing worries developers of nanoparticle cancer drugs , 2016, Nature.

[56]  S. Sen,et al.  Matrix Elasticity Directs Stem Cell Lineage Specification , 2006, Cell.

[57]  M. Mahmoudi,et al.  Regulation of stem cell fate by nanomaterial substrates. , 2015, Nanomedicine.

[58]  V. Miller,et al.  Reporting of sex as a variable in cardiovascular studies using cultured cells , 2011, Biology of Sex Differences.

[59]  Ludmila V. Danilova,et al.  Detection and localization of surgically resectable cancers with a multi-analyte blood test , 2018, Science.

[60]  Alaaldin M. Alkilany,et al.  Misinterpretation in Nanotoxicology: A Personal Perspective. , 2016, Chemical research in toxicology.

[61]  Theresa M. Wizemann,et al.  Exploring the biological contributions to human health: does sex matter? , 2001, Journal of women's health & gender-based medicine.

[62]  M. Papi,et al.  A protein corona-enabled blood test for early cancer detection. , 2017, Nanoscale.

[63]  David E. Goldberg,et al.  Genetic algorithms and Machine Learning , 1988, Machine Learning.

[64]  D. Ingber,et al.  From 3D cell culture to organs-on-chips. , 2011, Trends in cell biology.

[65]  Morteza Mahmoudi,et al.  Cell "vision": complementary factor of protein corona in nanotoxicology. , 2012, Nanoscale.

[66]  Hyeon-soo Park,et al.  Gender-specific differences in PPARγ regulation of follicular helper T cell responses with estrogen , 2016, Scientific Reports.

[67]  J. Vallée,et al.  Ex situ evaluation of the composition of protein corona of intravenously injected superparamagnetic nanoparticles in rats. , 2014, Nanoscale.

[68]  J. Enghild,et al.  Female versus male biological identities of nanoparticles determine the interaction with immune cells in fish , 2017 .

[69]  Paul Rees,et al.  Statistical analysis of nanoparticle dosing in a dynamic cellular system. , 2011, Nature nanotechnology.

[70]  Hicham Fenniri,et al.  Widespread Nanoparticle-Assay Interference: Implications for Nanotoxicity Testing , 2014, PloS one.

[71]  P. White,et al.  Characterizing Nanoparticles in Biological Matrices: Tipping Points in Agglomeration State and Cellular Delivery In Vitro. , 2017, ACS nano.

[72]  Morteza Mahmoudi,et al.  Nanotoxicology: advances and pitfalls in research methodology. , 2015, Nanomedicine.

[73]  Chawnshang Chang,et al.  Suppression Versus Induction of Androgen Receptor Functions by the Phosphatidylinositol 3-Kinase/Akt Pathway in Prostate Cancer LNCaP Cells with Different Passage Numbers* , 2003, Journal of Biological Chemistry.

[74]  Robert A. Weinberg,et al.  EMT in cancer , 2018, Nature Reviews Cancer.

[75]  P. Janmey,et al.  Mechanical Properties of the Cytoskeleton and Cells. , 2017, Cold Spring Harbor perspectives in biology.

[76]  Mojca Pavlin,et al.  Dispersion of Nanoparticles in Different Media Importantly Determines the Composition of Their Protein Corona , 2017, PloS one.

[77]  Andrew Emili,et al.  Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. , 2014, ACS nano.

[78]  P. Janmey,et al.  Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. , 2005, Cell motility and the cytoskeleton.

[79]  K. Landfester,et al.  Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake. , 2016, Nanoscale.

[80]  Iseult Lynch,et al.  What the cell "sees" in bionanoscience. , 2010, Journal of the American Chemical Society.

[81]  C. E. McCormack,et al.  Do you know the sex of your cells? , 2014, American journal of physiology. Cell physiology.

[82]  L. Griffith,et al.  Capturing complex 3D tissue physiology in vitro , 2006, Nature Reviews Molecular Cell Biology.

[83]  Ron C. Hardman.  A Toxicologic Review of Quantum Dots: Toxicity Depends on Physicochemical and Environmental Factors , 2005, Environmental health perspectives.

[84]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[85]  Maryam Mobed-Miremadi,et al.  Machine learning provides predictive analysis into silver nanoparticle protein corona formation from physicochemical properties. , 2018, Environmental science. Nano.

[86]  K J Johanson,et al.  Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. , 1984, Biochemical and biophysical research communications.

[87]  P. Kantoff,et al.  Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.

[88]  Ashley M. Laughney,et al.  Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle , 2015, Science Translational Medicine.

[89]  Luca Digiacomo,et al.  Personalized liposome-protein corona in the blood of breast, gastric and pancreatic cancer patients. , 2016, The international journal of biochemistry & cell biology.

[90]  Istvan Toth,et al.  Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. , 2011, Nature nanotechnology.

[91]  Ke Xu,et al.  Effect of Cell Sex on Uptake of Nanoparticles: The Overlooked Factor at the Nanobio Interface. , 2018, ACS nano.

[92]  Kreuter,et al.  Preparation, characterization and cytotoxicity of methylmethacrylate copolymer nanoparticles with a permanent positive surface charge. , 1997, International journal of pharmaceutics.

[93]  D. E. Discher,et al.  Matrix elasticity directs stem cell lineage — Soluble factors that limit osteogenesis , 2009 .

[94]  G. Caracciolo,et al.  In vivo protein corona patterns of lipid nanoparticles , 2017 .

[95]  Joachim O Rädler,et al.  Understanding the Kinetics of Protein–Nanoparticle Corona Formation , 2016, ACS nano.

[96]  M. Mahmoudi,et al.  Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide. , 2015, Nanoscale.

[97]  A. Nel,et al.  New Insights into "Permeability" as in the Enhanced Permeability and Retention Effect of Cancer Nanotherapeutics. , 2017, ACS nano.